Replies to post #387659 on Innovation Pharmaceuticals Inc (IPIX)

[CallMeCrazy]

Article published 25 January 2022

Brilacidin, a COVID-19 Drug Candidate, demonstrates broad-spectrum antiviral activity against human coronaviruses OC43, 229E and NL63 through targeting both the virus and the host cell
Yanmei Hu,Hyunil Jo,William F. DeGrado,Jun Wang
First published: 25 January 2022 https://doi.org/10.1002/jmv.27616

https://onlinelibrary.wiley.com/doi/10.1002/jmv.27616